Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce
Korea-based Medison is hoping to expand its share of the U.S. ultrasound market with systems that offer color digital imaging capability and high-end live 3D rendering of fetal and organ movements. Carrying the load for these aspirations are SonoAce Pico, which is being targeted to private-practice obstetricians and gynecologists, internists, radiologists, emergency departments, and small breast-imaging centers, and flagship Accuvix XQ for routine 2D studies and high-resolution and live 3D scans. (Prototypes of the two systems were unveiled at the 2002 RSNA meeting.)
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.